Next Article in Journal
Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives
Next Article in Special Issue
Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine
Previous Article in Journal
Association of Cerebral Venous Thrombosis with mRNA COVID-19 Vaccines: A Disproportionality Analysis of the World Health Organization Pharmacovigilance Database
Previous Article in Special Issue
Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination
 
 
Article

Article Versions Notes

Vaccines 2022, 10(5), 801; https://doi.org/10.3390/vaccines10050801
Action Date Notes Link
article pdf uploaded. 18 May 2022 18:58 CEST Version of Record https://www.mdpi.com/2076-393X/10/5/801/pdf-vor
article xml file uploaded 20 May 2022 16:46 CEST Original file -
article xml uploaded. 20 May 2022 16:46 CEST Update https://www.mdpi.com/2076-393X/10/5/801/xml
article pdf uploaded. 20 May 2022 16:46 CEST Updated version of record https://www.mdpi.com/2076-393X/10/5/801/pdf
article html file updated 20 May 2022 16:48 CEST Original file -
article html file updated 3 August 2022 00:34 CEST Update https://www.mdpi.com/2076-393X/10/5/801/html
Back to TopTop